<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ito K</submitter><funding>American Cancer Society</funding><funding>Breast Cancer Research Foundation</funding><funding>Susan G. Komen</funding><funding>New York State Department of Health</funding><funding>NCI NIH HHS</funding><pagination>946-957</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10977041</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(3)</volume><pubmed_abstract>Epithelial-mesenchymal transition (EMT) in cancer promotes metastasis and chemotherapy resistance. A subset of triple-negative breast cancer (TNBC) exhibits a mesenchymal gene signature that is associated with poor patient outcomes. We previously identified PTK6 tyrosine kinase as an oncogenic driver of EMT in a subset of TNBC. PTK6 induces EMT by stabilizing SNAIL, a key EMT-initiating transcriptional factor. Inhibition of PTK6 activity reverses mesenchymal features of TNBC cells and suppresses their metastases by promoting SNAIL degradation via a novel mechanism. In the current study, we identify membrane-associated RING-CH2 (MARCH2) as a novel PTK6-regulated E3 ligase that promotes the ubiquitination and degradation of SNAIL protein. The MARCH2 RING domain is critical for SNAIL ubiquiti</pubmed_abstract><journal>Cancer research communications</journal><pubmed_title>MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases.</pubmed_title><pmcid>PMC10977041</pmcid><funding_grant_id>C36612GG</funding_grant_id><funding_grant_id>P30 CA196521</funding_grant_id><funding_grant_id>PDF17488499</funding_grant_id><funding_grant_id>RSG-18-044-01-LIB</funding_grant_id><funding_grant_id>CCRCR17499360</funding_grant_id><pubmed_authors>Harada I</pubmed_authors><pubmed_authors>Port E</pubmed_authors><pubmed_authors>Nayak A</pubmed_authors><pubmed_authors>Ito K</pubmed_authors><pubmed_authors>Zhu J</pubmed_authors><pubmed_authors>Byerly JH</pubmed_authors><pubmed_authors>Irie HY</pubmed_authors><pubmed_authors>Martinez C</pubmed_authors><pubmed_authors>Sato K</pubmed_authors><pubmed_authors>Lee E</pubmed_authors><pubmed_authors>Tripathi E</pubmed_authors></additional><is_claimable>false</is_claimable><name>MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases.</name><description>Epithelial-mesenchymal transition (EMT) in cancer promotes metastasis and chemotherapy resistance. A subset of triple-negative breast cancer (TNBC) exhibits a mesenchymal gene signature that is associated with poor patient outcomes. We previously identified PTK6 tyrosine kinase as an oncogenic driver of EMT in a subset of TNBC. PTK6 induces EMT by stabilizing SNAIL, a key EMT-initiating transcriptional factor. Inhibition of PTK6 activity reverses mesenchymal features of TNBC cells and suppresses their metastases by promoting SNAIL degradation via a novel mechanism. In the current study, we identify membrane-associated RING-CH2 (MARCH2) as a novel PTK6-regulated E3 ligase that promotes the ubiquitination and degradation of SNAIL protein. The MARCH2 RING domain is critical for SNAIL ubiquiti</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-07-16T04:13:01.433Z</modification><creation>2025-04-05T23:18:16.834Z</creation></dates><accession>S-EPMC10977041</accession><cross_references><pubmed>38457262</pubmed><doi>10.1158/2767-9764.CRC-23-0090</doi></cross_references></HashMap>